Systemic dexamethasone for the prevention of cisplatin-induced ototoxicity

European Archives of Oto-Rhino-Laryngology

Volumn 270, Issue 5, 2013, Pages 1597-1605

  Waissbluth, Sofia ^a   Salehi, Pezhman ^a   He, Xinying ^b   Daniel, Sam J ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Cisplatin; Cochlea; Dexamethasone; Inflammation; Ototoxicity

Indexed keywords

CISPLATIN; DEXAMETHASONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; CORTI ORGAN; EVOKED BRAIN STEM AUDITORY RESPONSE; EXPERIMENTAL GUINEA PIG; FEMALE; HAIR CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCANNING ELECTRON MICROSCOPY; SPIRAL GANGLION; SPIRAL LIGAMENT; STEROID THERAPY; STRIA VASCULARIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; CISPLATIN; COCHLEA; DEXAMETHASONE; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; GUINEA PIGS; HEARING LOSS, SENSORINEURAL; MICROSCOPY, ELECTRON, SCANNING; ORGAN OF CORTI; PROSPECTIVE STUDIES; SPIRAL GANGLION; SPIRAL LIGAMENT OF COCHLEA; STRIA VASCULARIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877153127     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-012-2150-0     Document Type: Article

References (29)

1. Rybak LP, Ramkumar V (2007) Ototoxicity. Kidney Int 72:931-935
2. Watanabe K, Inai S, Jinnouchi K, Baba S, Yagi T (2003) Expression of caspase-activated deoxyribonuclease (CAD) and caspase 3 (CPP32) in the cochlea of cisplatin (CDDP)-treated guinea pigs. Auris Nasus Larynx 30:219-225
3. van Ruijven MW, de Groot JC, Klis SF, Smoorenburg GF (2005) The cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study. Hear Res 205:241-248
4. Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V (2007) Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res 226:157-167
5. Rybak LP (2007) Mechanisms of cisplatin ototoxicity and progress in otoprotection. Curr Opin Otolaryngol Head Neck Surg 15:364-369
6. So H, Kim H, Lee JH, Park C, Kim Y, Kim E, Kim JK, Yun KJ, Lee KM, Lee HY, Moon SK, Lim DJ, Park R (2007) Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB. J Assoc Res Otolaryngol 8:338-355
7. Barnes PJ (1997) Nuclear factor-kappa B. Int J Biochem Cell Biol 29:867-870
8. Keithley EM, Wang X, Barkdull GC (2008) Tumor necrosis factor alpha can induce recruitment of inflammatory cells to the cochlea. Otol Neurotol 29:854-859
9. Shirwany NA, Seidman MD, Tang W (1998) Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig. Am J Otol 19:230-235
10. Hill GW, Morest DK, Parham K (2008) Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections. Otol Neurotol 29:1005-1011
11. Barnes PJ (2005) Molecular mechanisms and cellular effects of glucocorticosteroids. Immunol Allergy Clin North Am 25:451-468
12. Wang D, Lippard SJ (2005) Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4:307-320
13. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286-290
14. Daldal A, Odabasi O, Serbetcioglu B (2007) The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs. Otolaryngol Head Neck Surg 137:747-752
15. Murphy D, Daniel SJ (2011) Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model. Otolaryngol Head Neck Surg 145:452-457
16. Paksoy M, Ayduran E, SanlI A, Eken M, AydIn S, Oktay ZA (2011) The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats. Med Oncol 28:615-621
17. Liu HJ, Dong MM, Chi FL (2006) Dexamethasone pharmacokinetics in Guinea pig inner ear perilymph. ORL J Otorhinolaryngol Relat Spec 68:93-98
18. van Ruijven MW, de Groot JC, Smoorenburg GF (2004) Time sequence of degeneration pattern in the guinea pig cochlea during cisplatin administration. A quantitative histological study. Hear Res 197:44-54
19. Waissbluth S, Dupuis I, Daniel SJ (2011) Protective effect of erdosteine against cisplatin-induced ototoxicity in a guinea pig model. Otolaryngol Head Neck Surg 146:627-632
20. Hartmann JT, Lipp HP (2003) Toxicity of platinum compounds. Expert Opin Pharmacother 4:889-901
21. Rutt AL, Hawkshaw MJ, Sataloff RT (2011) Incidence of tympanic membrane perforation after intratympanic steroid treatment through myringotomy tubes. Ear Nose Throat J 90:E21
22. Banerjee A, Parnes LS (2004) The biology of intratympanic drug administration and pharmacodynamics of round window drug absorption. Otolaryngol Clin North Am 37:1035-1051
23. Wagenblast J, Arnoldner C, Gstöttner W, Bisdas S, Mörtel S, May A, Hambek M (2010) Does dexamethasone inhibit the antineoplastic effect of cisplatin and docetaxel in head and neck cancer cells? Anticancer Res 30:123-127
24. Meech RP, Campbell KC, Hughes LP, Rybak LP (1998) A semiquantitative analysis of the effects of cisplatin on the rat stria vascularis. Hear Res 124:44-59
25. Sluyter S, Klis SF, de Groot JC, Smoorenburg GF (2003) Alterations in the stria vascularis in relation to cisplatin ototoxicity and recovery. Hear Res 185:49-56
26. Kohn S, Fradis M, Podoshin L, Ben David Y, Zidan J, Robinson E, Nir I (1991) Toxic effects of cisplatin alone and in combination with gentamicin in stria vascularis of guinea pigs. Laryngoscope 101:709-716
27. Tange RA, Vuzevski VD (1984) Changes in the stria vascularis of the guinea pig due to cis-platinum. Arch Otorhinolaryngol 239:41-47
28. Rarey KE, Curtis LM, ten Cate WJ (1993) Tissue specific levels of glucocorticoid receptor within the rat inner ear. Hear Res 64:205-210
29. ten Cate WJ, Curtis LM, Small GM, Rarey KE (1993) Localization of glucocorticoid receptors and glucocorticoid receptor mRNAs in the rat cochlea. Laryngoscope 103:865-871